knee osteoartritis. Primary arthrosis of other joints
Conditions
Interventions
Intervention 1: Receive topical consumption of sambucus ebulus gel, Every 8 hour on all of site of knee for 30 days. Intervention 2: Receive topical consumption of Diclofenac gel, Every 8 hour
Treatment - Drugs
Receive topical consumption of sambucus ebulus gel, Every 8 hour on all of site of knee for 30 days
Receive topical consumption of Diclofenac gel, Every 8 hour on all of site of knee for 30 days
Sponsors
Vice Chancellor for research, Shahid Sadoughei University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: age: 30-60 years; A history of knee pain for at least 3 months; Mild to moderate Osteoarthritis (grade 1 and 2) based on Kellegren-Lawrence grading scale; Exclusion Criteria: 1-Allergy to Sambucus ebulus & Diclofenac gel; Skin lesions in the knee; Osteoarthritis secondary to Rheumatic disease such as Rheumatoid Arthritis, Gout, Infectious Arthritis, Metabolic Arthritis, Traumatic Arthritis; Knee joint replacement surgery; Oral and topical steroid therapy within 14 days prior to study; Intra-articular steroid injections within 90 days prior to study; Pregnancy and Lactation; Addiction to alcohol and drugs; Radiculopathy and Neuropathy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Baseline, 2 and 4 weeks after intervention. Method of measurement: WOMAC questionnaire.;Stiffness. Timepoint: Baseline, 2 and 4 weeks after intervention. Method of measurement: WOMAC questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical function. Timepoint: Baseline, 2 and 4 weeks after intervention. Method of measurement: WOMAC questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzie Jabbari
Traditional Medicine Faculty of Ardakan, Shahid Sadoughei University of Medical Sciences
Outcome results
None listed